Abstract

Objectives: Reperfusion of ischemic hearts with warm, substrate-enriched, blood cardioplegia may alleviate post-ischemic metabolic and functional derangements. This study investigates this possibility using (31)P magnetic resonance (MR) spectroscopy. Methods: Fifteen blood-perfused Langendorff pig hearts were subjected to 30 min of total, normothermic ischemia. Control hearts (n=8) were reperfused with blood for 40 min. Experimental hearts (n=7) received 20 min of aspartate/glutamate (asp/glu) enriched blood cardioplegic solution, followed by 20 min of normal blood. (31)P MR spectroscopy was used to observe cellular energetics and intracellular pH (pHi) throughout the experiments. Left-ventricular function and myocardial oxygen consumption were evaluated before and after ischemia. Results: MR spectra showed no improvement in the rate or extent of high-energy phosphate recovery with asp/glu cardioplegia, but showed a transient increase in pHi during cardioplegic reperfusion (p<0.05). This, however, did not affect post-ischemic recovery of high energy metabolites, myocardial function or oxygen consumption. Conclusions: This study raises questions regarding the potential beneficial effects of asp/glu enriched secondary cardioplegic solution on functional or metabolic status of stunned pig hearts. Extrapolation of these results to humans should be viewed with caution. Keywords: Magnetic resonance; Pig heart; Aspartate; Glutamate; Cardioplegia; Myocardial stunning.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.